IntelligentMDx (privately held) announced today that the U.S. Food and Drug Administration (FDA) has cleared its automated molecular diagnostic test that detects the presence of vanA and vanB genes that can be associated with vancomycin-resistant enterococci (VRE).
Saelig has introduced the GSP-930 - a 3GHz Spectrum Analyzer designed on a new generation platform to offer high stability, a large screen display, light weight and compact size. Its advanced Spectrogram and Topography features greatly expand the application range of this versatile RF analysis instrument.
Millstone Medical Outsourcing announced today that the company has welcomed a variety of advanced equipment to its mechanical inspection cells in both Fall River and Olive Branch facilities.
Triag workholding systems combine the characteristics and performance of a dedicated fixture in a modular platform. Triag's modular work holding systems use compact clamp, power clamp and microclamp technology to hold from mid-size to very small parts in high densities, while allowing easy part change for fast retooling.
Siemens CEO Peter Loescher may be booted from the corner office, according to a surprise weekend announcement from the healthcare giant's board of directors. Loescher's pending departure, which comes 4 years before the end of his contract, will likely be finalized at Wednesday's board meeting, according to company reports.
Electronics engineers requiring reliable magnetic components for high voltage designs will find the Perfect-Layer Coil Series from Innovative Power, Inc. (IPI), is flexible and ideal for a wide range of applications. IPI’s perfect-layer coil winding technology offers a number of advantages.
NeuroSigma is one step closer to bringing its epilepsy treatment to U.S. markets with FDA approval to begin its Phase III clinical studies. Currently only available for investigational use in the U.S., NeuroSigma's Monarch eTNS system is already on the shelves in Europe and Canada.
The highly aggressive sterilization methods used on medical devices to help combat healthcare-associated infections (HAIs) are harsh and can cause color shift. Medical devices that become discolored from sterilization can comprise patient safety and public peace of mind.
Haemonetics Corp. took a Wall Street dip after posting a hard swing to the red and adjusted per-share earnings just shy of analysts' expectations. Braintree, Mass.-based Haemonetics missed per-share analyst estimates by 1 penny and posted a nearly full reversal of the profits reported for this quarter last year...
Broken bones and joint replacements may someday heal faster, thanks to an unusual coating for medical implants under development at The Ohio State University. Researchers have found that bone cells grow and reproduce faster on a textured surface than they do on a smooth one—and they grow best when they can cling to a microscopic shag carpet made of tiny metal oxide wires.
The discovery of a gene's function in E. coli and other bacteria might lead to a probiotic to prevent the most common type of kidney stone, according to a Purdue University study. Human cells can't metabolize oxalate, an acidic chemical found in nearly all plants we eat, so any oxalate we absorb from food must be excreted from the body.
Fitness fanatics may soon be able to gauge if their hard work is paying off without the need for weighing scales thanks to a new device that can instantly tell if your body is burning fat. The portable, pocket-sized sensor, produced by a group of researchers in Japan, works by measuring increased levels of acetone on the breath.
ReVision Optics said it's raised $55 million from a consortium of investors and closed enrollment in a clinical trial of its Raindrop near vision inlay to treat presbyopia. The Lake Forest, Calif.-based company said all of its existing backers – Canaan Partners, ProQuest Investments, InterWest Partners and Domain Assoc. – were joined by new investors Johnson & Johnson Development Corp. and RusnanoMedInvest in the round.
Hansen Medical said it agreed to pay out $8.5 million in cash and stock to put to rest a shareholders' lawsuit filed over its 2009 restatement of revenues. The Mountain View, Calif.-based robotic surgery company said it agreed to pay $4.25 million in cash and another $4.5 million worth of its own stock to settle the lawsuit.
California-based Caymus Medical is looking to raise $10 million through sales of equity, according to an SEC filing submitted this week. Caymus has raised $3.9 million so far from 19 investors, according to the filing. Investors' names were not listed and the company didn't specify what it plans to do with the funds.